These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Public sector seeks to bridge 'valley of death'. Moran N Nat Biotechnol; 2007 Mar; 25(3):266. PubMed ID: 17344867 [No Abstract] [Full Text] [Related]
23. South Korean biotechnology--a rising industrial and scientific powerhouse. Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684 [No Abstract] [Full Text] [Related]
24. Harnessing genomics and biotechnology to improve global health equity. Singer PA; Daar AS Science; 2001 Oct; 294(5540):87-9. PubMed ID: 11588248 [TBL] [Abstract][Full Text] [Related]
25. The emergence of Egyptian biotechnology from generics. Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680 [No Abstract] [Full Text] [Related]
26. The rice genome. The cereal of the world's poor takes center stage. Cantrell RP; Reeves TG Science; 2002 Apr; 296(5565):53. PubMed ID: 11935006 [No Abstract] [Full Text] [Related]
27. Caught between paradise and power: public health, pathogenic threats, and the axis of illness. Fidler DP McGeorge Law Rev; 2004; 35(1):45-104. PubMed ID: 17063603 [No Abstract] [Full Text] [Related]
28. The Human Genome Project: a public good. Hudson K Health Matrix Clevel; 2002; 12(2):367-75. PubMed ID: 12430360 [No Abstract] [Full Text] [Related]
29. Global public-private partnerships: Part I--A new development in health? Buse K; Walt G Bull World Health Organ; 2000; 78(4):549-61. PubMed ID: 10885184 [TBL] [Abstract][Full Text] [Related]
31. Public-private partnerships: an overview. Widdus R Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S1-8. PubMed ID: 16085172 [TBL] [Abstract][Full Text] [Related]
32. Initial lessons from public-private partnerships in drug and vaccine development. Wheeler C; Berkley S Bull World Health Organ; 2001; 79(8):728-34. PubMed ID: 11545329 [TBL] [Abstract][Full Text] [Related]
33. Public-private partnership: from there to here. Croft SL Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S9-14. PubMed ID: 16087204 [TBL] [Abstract][Full Text] [Related]
34. A source of innovation. Gillespie DG Integration; 1992 Dec; (34):2-7. PubMed ID: 12317827 [TBL] [Abstract][Full Text] [Related]
35. Assessing the impact of the green revolution, 1960 to 2000. Evenson RE; Gollin D Science; 2003 May; 300(5620):758-62. PubMed ID: 12730592 [TBL] [Abstract][Full Text] [Related]
36. Medicine. The need for a global HIV vaccine enterprise. Klausner RD; Fauci AS; Corey L; Nabel GJ; Gayle H; Berkley S; Haynes BF; Baltimore D; Collins C; Douglas RG; Esparza J; Francis DP; Ganguly NK; Gerberding JL; Johnston MI; Kazatchkine MD; McMichael AJ; Makgoba MW; Pantaleo G; Piot P; Shao Y; Tramont E; Varmus H; Wasserheit JN Science; 2003 Jun; 300(5628):2036-9. PubMed ID: 12829768 [TBL] [Abstract][Full Text] [Related]
37. [Inequalities of access to care and in participation in research on a worldwide level: ethical problems]. France. Comite consultatif national d'ethique pour les sciences de la vie et de la sante J Int Bioethique; 2005; 16(3-4):152-3. PubMed ID: 17058809 [No Abstract] [Full Text] [Related]
38. Globalisation and public health-overview and a Swedish perspective. Kjellström T; Håkansta C; Hogstedt C Scand J Public Health Suppl; 2007 Dec; 70():2-68. PubMed ID: 18030647 [No Abstract] [Full Text] [Related]
39. [International health research: priorities and commitment]. Kruse AY; Bygbjerg IC Ugeskr Laeger; 2006 Sep; 168(36):2996-8. PubMed ID: 16999885 [TBL] [Abstract][Full Text] [Related]